SCHEMBL8947352

SCHEMBL8947352

Cc1ccc2c(/N=N/c3cc(C)c(C)cc3C)c(O)c(S(=O)(=O)O)cc2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.73
▸ HIF1A Q16665 2/20 0.73
▸ CYP1A2 P05177 3/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ THRB P10828 3/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ ENPP2 Q13822 6/20 0.47
▸ BRD4 O60885 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ MPL P40238 2/20 0.46
▸ SUMO2 P61956 1/20 0.44
▸ SUMO1 P63165 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP3 Q9H4L4 1/20 0.44
▸ SENP2 Q9HC62 1/20 0.44
▸ SENP1 Q9P0U3 1/20 0.44
▸ TP53 P04637 2/20 0.43
▸ CREBBP Q92793 1/20 0.43
▸ PHLPP2 Q6ZVD8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947349 0.91 ALDH1A1 (0.87) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL4579446 0.88 HIF1A (0.78) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL6846279 0.85 HIF1A (1.00) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL8816124 0.85 HIF1A (1.00) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL4068193 0.85 HIF1A (1.00) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL10622991 0.84 HIF1A (0.98) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL8947271 0.82 THRB (0.78) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL20306013 0.79 ALDH1A1 (0.58) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL1268489 0.79 ALDH1A1 (0.58) ALDH1A1HIF1ACYP1A2MEN1KMT2A
SCHEMBL29617554 0.79 ALDH1A1 (0.58) ALDH1A1HIF1ACYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9504637-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-11-29 — — US disclosed
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2016-04-21 — — US disclosed
US-9248086-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2016-02-02 — — US disclosed
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2015-06-25 — — US disclosed
US-8932370-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2015-01-13 — — US disclosed
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-11-06 — — US disclosed
US-8758451-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2014-06-24 — — US disclosed
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2014-01-16 — — US disclosed
US-8444715-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2013-05-21 — — US disclosed
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2012-11-01 — — US disclosed
US-8187340-B2 Coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2012-05-29 — — US disclosed
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2011-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120272990-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885
US-20110154583-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885
US-20160106648-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885
US-20140013520-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885
US-20150174026-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885
US-20140326269-A1 COLORING AGENTS AND METHODS OF USE THEREOF MPO, HLA-C, ADH7 ALDH1A1 192/4885HIF1A 891/4885CYP1A2 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback